(Q35146199)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Alexander Stojadinovic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Ari Brooks

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Axel Hoos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

David P Jaques

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Kevin C Conlon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Surgeons

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

954-964

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

Randomized clinical trials in pancreatic cancer.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Randomized prospective trial of pylorus-preserving vs. Classic duodenopancreatectomy (Whipple procedure): initial clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Occlusion of the pancreatic duct versus pancreaticojejunostomy: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Role of octreotide in the prevention of postoperative complications following pancreatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater--results of a controlled, prospective, randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900010-3

7 January 2021

10.1016/S1072-7515(03)00010-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12788434%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference